Real-World Safety Outcomes with Brolucizumab in Neovascular Age-Related Macular Degeneration: Findings from the IRIS® Registry.

Autor: Zarbin, Marco A.1 (AUTHOR) zarbin@njms.rutgers.edu, MacCumber, Mathew W.2,3 (AUTHOR), Karcher, Helene4 (AUTHOR), Adiguzel, Eser5 (AUTHOR), Mayhook, Andrew6 (AUTHOR), LaPrise, Andrew7 (AUTHOR), Bilano, Ver L.8 (AUTHOR), Igwe, Franklin4 (AUTHOR), Ip, Michael S.9 (AUTHOR), Wykoff, Charles C.10,11 (AUTHOR)
Zdroj: Ophthalmology & Therapy. May2024, Vol. 13 Issue 5, p1357-1368. 12p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje